Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461395 · ClinicalTrials.gov registry record
Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm
A clinical trial, sponsored by University of South Florida.
- Completed
- Registry status
- 84
- Enrollment target
NCT01461395: Completed study, sponsored by University of South Florida.
NCT01461395 is a clinical trial that has completed, run by University of South Florida. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461395 has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to find a non-invasive way to discover DNA (deoxyribonucleic acid, which is the genetic material inside your cells) alterations in the sperm's head, in the near future leading us to choose the "good sperm" in a simplified manner. This could then increase chances of a successful in-vitro fertilization (IVF) treatment when there are sperm abnormalities.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-06 |
What the finished NCT01461395 record still lists
NCT01461395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01461395 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461395 about?
NCT01461395 is a clinical study titled "Polscope Sperm: A Non-invasive Method to Assess DNA Damage in Individual Sperm". The purpose of this study is to find a non-invasive way to discover DNA (deoxyribonucleic acid, which is the genetic material inside your cells) alterations in the sperm's head, in the near future leading us to choose the "good sperm" in a simplified manner. This could then increase chances of a suc...
What is the current status of trial NCT01461395?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2008-10. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT01461395?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia